ReviewCureus2025

Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials.

Razaz Galal Mirghani Idris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.